A Cross-Sectional Study of the Correlation Between the Atherogenic Index of Plasma and Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes
DOI: https://doi.org/10.2147/DMSO.S375300
2022-07-30
Abstract:Jie Lin, 1– 4 Hang Li, 1– 4 Qin Wan 1– 4 1 Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China; 2 Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, People's Republic of China; 3 Sichuan Clinical Research Center for Nephropathy, Luzhou, People's Republic of China; 4 Cardiovascular and Metabolic Diseases Key Laboratory of Luzhou, Luzhou, People's Republic of China Correspondence: Qin Wan, Tel +86 138 8274 6971, Email Purpose: The main objective of this study was to examine the possible association between the atherogenic index of plasma (AIP) and the prevalence of nonalcoholic fatty liver disease (NAFLD) in Chinese individuals with type 2 diabetes mellitus (T2DM). Patients and methods: In this survey, data from 1074 patients with T2DM were retrospectively extracted. The correlations between each variable and NAFLD were determined by univariate analysis, and then, the statistically significant variables were evaluated for their association with AIP and NAFLD by multivariate regression analysis. Results: AIP levels were significantly higher in all males and females with NAFLD than those without NAFLD (p< 0.001). The prevalence of NAFLD increased progressively throughout the AIP quartiles (trend P < 0.001) and accounted for possible variables in Model 3 of the multivariate logistic regression analysis (OR: 2244.984). In terms of sensitivity and specificity, the AIP index was found to be 65.0% and 90.1% accurate, respectively, with a 95% CI of 0.804– 0.893. According to a stratified analysis, females, patients over the age of 56 and current nonsmokers were found to have a higher chance of developing NAFLD. Conclusion: T2DM individuals with NAFLD were found to have a higher AIP index than those without NAFLD. The prevalence and progression of NAFLD in T2DM patients may be influenced by the AIP index. Keywords: type 2 diabetes mellitus, nonalcoholic fatty liver disease, atherogenic index of plasma, diagnostic ability, cross-sectional study Fat accumulation in the liver is caused by complex interactions between hereditary factors and external factors, such as metabolic stress. 1 A common chronic complication of diabetes mellitus is characterized as nonalcoholic fatty liver disease (NAFLD). 2–5 NAFLD is a hepatic manifestation of metabolic syndrome that is typically linked to type 2 diabetes mellitus (T2DM), obesity, dyslipidemia, and other metabolic disorders. 6–8 Increased obesity and diabetes incidence has led to a rise in the number of NAFLD problems in T2DM patients. 9–11 According to the literature, the occurrence of NAFLD in diabetic patients is 40%-70%. 6,12–15 The incidence of NAFLD was 27.85% in the T2DM group of a Chinese cohort study. 16 Therefore, early prevention of the development of NAFLD in patients with T2DM is essential. The atherogenic index of plasma (AIP) is an efficient predictor of atherosclerosis and coronary heart disease risk. 17,18 According to a number of studies, an elevated AIP index is linked to the development of diabetes, coronary heart disease, NAFLD, and hypertension, and it also has good predictive value. 19–22 However, there is no research on the link between AIP and NAFLD in people with T2DM. Therefore, the aim of this study was to analyze the association between AIP and NAFLD in patients with T2DM and to investigate the potential of AIP as a potential risk factor for NAFLD. We screened 1074 patients from the Department of Endocrinology and Metabolism of the Affiliated Hospital of Southwest Medical University from March 2018 to May 2019. There were 542 males and 532 females aged 18 to 80 years, with an average age of 56.17 ± 11.54 years. Inclusion criteria: the American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" for diabetes mellitus, published in 2021, were completely met by all T2DM patients. 23 Exclusion criteria: type 1 diabetes, specific types of diabetes due to other causes and gestational diabetes mellitus defined by the ADA "Standards of Medical Care in Diabetes" (2021); 23 infectious diseases, severe liver insufficiency, severe cardiovascular diseases, psychiatric diseases, alcoholism and incomplete clinical data. The study complied with the ethical standards of the Declaration of Helsinki (2013) and was approved by the Ethics Committee of the Affiliated Hospital of Southwest Medical University (file number: 2018017). 24 The patients gave their informed consent. Data regarding sex, age, duration of T2DM, and history of smoking (smoking defined as >1 cigarette/d, las -Abstract Truncated-